Effectiveness of smoking cessation pharmacotherapies during pregnancy: A multi‐national population‐based study
Varenicline appears to be more effective at smoking cessation than nicotine replacement therapy during pregnancy. The uncertainty about the real-world effectiveness of nicotine replacement therapy and bupropion remains as this study's analyses were impacted by non-adherence and biased by unmeasured confounding.
Authors
- S Thomas Donald
- Duong Thuy Tran (ORCID: https://orcid.org/0000-0002-1454-9462)
- Sallie‐Anne Pearson (ORCID: https://orcid.org/0000-0001-7137-6855)
- Lianne Parkin (ORCID: https://orcid.org/0000-0002-6824-6176)
- Jacqueline M. Cohen (ORCID: https://orcid.org/0000-0002-7300-0488)
- Johan Reutfors (ORCID: https://orcid.org/0000-0003-1372-4262)
- Carolyn E. Cesta (ORCID: https://orcid.org/0000-0001-5759-9366)
- Nicholas Zwar (ORCID: https://orcid.org/0000-0001-6462-9121)
- Helga Zoëga (ORCID: https://orcid.org/0000-0003-0761-9028)
- Kari Furu
- Annelies L. Robijn
- Alys Havard
Institutions
- Bond University (AU)
- Norwegian Institute of Public Health (NO)
- University of Iceland (IS)
- Karolinska Institutet (SE)
- UNSW Sydney (AU)
- University of Otago (NZ)
Publication Details
- Journal
- Addiction
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1111/add.70290
- Primary Topic
- Smoking Behavior and Cessation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Australian Government
- University of New South Wales
- Department of Health and Aged Care, Australian Government
- Norges Forskningsråd
- NSW Ministry of Health
- Medical Research Council
- National Health and Medical Research Council
- National Drug and Alcohol Research Centre